LEO Pharma AS:医療機器:M&Aディール及び事業提携情報

◆英語タイトル:LEO Pharma AS - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C7174
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:29
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:デンマーク
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
LEO Pharma A/S (LEO Pharma), a subsidiary of LEO Foundation is a research-based pharmaceutical company. It discovers, develops, manufactures and commercializes pharmaceuticals in therapeutic areas dermatology and thrombosis. The company focuses on the treatment of diseases such as psoriasis, eczema, skin infections, actinic keratosis and non-melanoma skin cancer, besides thrombosis. It also manufactures and markets products for the treatment of diseases in the areas of cardiovascular, bacterial infections, coagulation, osteoporosis and renal care. LEO Pharma markets its products worldwide and has presence in countries across Europe, the Middle East, Africa, Asia, North America, Central America, South America and Oceania. LEO Pharma is headquartered in Ballerup, Denmark.

LEO Pharma AS – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
LEO Pharma A/S, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
LEO Pharma A/S, Medical Equipment Deals By Type, 2012 to YTD 2018 6
LEO Pharma A/S, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
LEO Pharma A/S, Medical Equipment, Deals By Market, 2012 to YTD 2018 8
LEO Pharma A/S, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
LEO Pharma A/S, Medical Equipment, Deal Details 10
Partnerships 10
Leo Pharma Enters into Licensing Agreement with Klox Technologies 10
LEO Pharma and FibroTx Enter into Partnership 11
Almirall and Leo Pharma Enter into Agreement 12
Klox Technologies and LEO Pharma to Form Joint Venture 13
LEO Pharma A/S – Key Competitors 14
LEO Pharma A/S – Key Employees 15
LEO Pharma A/S – Locations And Subsidiaries 16
Head Office 16
Other Locations & Subsidiaries 16
Recent Developments 19
Financial Announcements 19
Mar 02, 2018: A record year for LEO Pharma 19
Apr 03, 2017: LEO Pharma 2016 result surpassed expectations 21
Corporate Communications 23
Aug 28, 2018: LEO Pharma appointed Olivier Bohuon as Board Director 23
May 28, 2018: LEO Pharma Names Christian Antoni as Senior Vice President for Global Development, R&D 24
Mar 20, 2018: LEO Pharma Appoints Rhonda Duffy To Lead Global Product Supply 25
Jun 23, 2017: LEO Pharma Appoints Chris Posner to Lead US Business 26
Other Significant Developments 27
Apr 12, 2018: LEO Pharma makes its first investment in microbiome technology – enters partnership with microbiome-therapeutics company Naked Biome 27
Mar 05, 2018: LEO Pharma and International Health Partners enter into partnership to help people in need 28
Appendix 29
Methodology 29
About GlobalData 29
Contact Us 29
Disclaimer 29

List of Tables
LEO Pharma A/S, Medical Equipment, Key Facts, 2017 2
LEO Pharma A/S, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
LEO Pharma A/S, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
LEO Pharma A/S, Medical Equipment Deals By Type, 2012 to YTD 2018 6
LEO Pharma A/S, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
LEO Pharma A/S, Deals By Market, 2012 to YTD 2018 8
LEO Pharma A/S, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Leo Pharma Enters into Licensing Agreement with Klox Technologies 10
LEO Pharma and FibroTx Enter into Partnership 11
Almirall and Leo Pharma Enter into Agreement 12
Klox Technologies and LEO Pharma to Form Joint Venture 13
LEO Pharma A/S, Key Competitors 14
LEO Pharma A/S, Key Employees 15
LEO Pharma A/S, Subsidiaries 16

List of Figures
LEO Pharma A/S, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
LEO Pharma A/S, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
LEO Pharma A/S, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
LEO Pharma A/S, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
LEO Pharma A/S, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
LEO Pharma A/S, Medical Equipment, Deals by Type, 2012 to YTD 2018 6
LEO Pharma A/S, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
LEO Pharma A/S, Medical Equipment, Deals by Market, 2012 to YTD 2018 8

★海外企業調査レポート[LEO Pharma AS:医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • comdirect bank AG:企業の戦略・SWOT・財務情報
    comdirect bank AG - Strategy, SWOT and Corporate Finance Report Summary comdirect bank AG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Yamada Denki Co Ltd:企業の戦略・SWOT・財務分析
    Yamada Denki Co Ltd - Strategy, SWOT and Corporate Finance Report Summary Yamada Denki Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Esperion Therapeutics Inc (ESPR):製薬・医療:M&Aディール及び事業提携情報
    Summary Esperion Therapeutics Inc (Esperion), a subsidiary of Pfizer Inc is a pharmaceutical company that develops and commercializes once-daily, oral and low-density lipoprotein cholesterol lowering therapies. The company develops oral therapies to treat patients with elevated low-density lipoprote …
  • SK Telecom Co., Ltd.:企業の戦略・SWOT・財務分析
    SK Telecom Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary SK Telecom Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Rockwell Automation, Inc.:企業の戦略・SWOT・財務分析
    Rockwell Automation, Inc. - Strategy, SWOT and Corporate Finance Report Summary Rockwell Automation, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Boubyan Petrochemical Co:企業の戦略・SWOT・財務分析
    Boubyan Petrochemical Co - Strategy, SWOT and Corporate Finance Report Summary Boubyan Petrochemical Co - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • ARCA biopharma Inc (ABIO):企業の財務・戦略的SWOT分析
    Summary ARCA Biopharma Inc (ARCA), formerly Nuvelo Inc is a developer of genetically targeted therapies for cardiovascular diseases. The company’s product candidate include Gencaro, a mild vasodilator and investigational pharmacologically unique beta-blocker that is being developed for the treatment …
  • Town Centre Securities Plc:企業の戦略・SWOT・財務情報
    Town Centre Securities Plc - Strategy, SWOT and Corporate Finance Report Summary Town Centre Securities Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • Intrinsic Therapeutics Inc-医療機器分野:企業M&A・提携分析
    Summary Intrinsic Therapeutics Inc (Intrinsic) is a medical device company that develops medical devices for the treatment of lumbar disc herniations. The company offers prosthesis for partial anulus replacement following discectomy surgery; prosthesis for partial anulus replacement; and anular clos …
  • Martin Marietta Materials Inc:企業のM&A・事業提携・投資動向
    Martin Marietta Materials Inc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Martin Marietta Materials Inc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and …
  • American Woodmark Corp (AMWD):企業の財務・戦略的SWOT分析
    American Woodmark Corp (AMWD) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • Dyadic International Inc (DYAI):企業の財務・戦略的SWOT分析
    Summary Dyadic International Inc (Dyadic) is a biotechnology company that develops gene expression platform for production of industrial enzymes and other proteins. The company utilizes C1 technology, an expression system based on the fungus Myceliophthora thermophila, to discover and manufacture bi …
  • A&W Food Services of Canada Inc.:戦略・SWOT・企業財務分析
    A&W Food Services of Canada Inc. - Strategy, SWOT and Corporate Finance Report Summary A&W Food Services of Canada Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, produ …
  • Northrop Grumman Aerospace Systems:企業の戦略・SWOT・財務情報
    Northrop Grumman Aerospace Systems - Strategy, SWOT and Corporate Finance Report Summary Northrop Grumman Aerospace Systems - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, p …
  • NR Electric Co Ltd:企業の戦略的SWOT分析
    NR Electric Co Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and ser …
  • Memphasys Ltd (MEM):製品パイプライン分析
    Summary Memphasys Ltd (Memphasys), formerly Nusep Holdings Ltd is a bio-separations company that develops and commercializes separation techniques based on its membrane technology. The company develops felix, a non-DNA damaging lab instrument for sperm separation that separates sperm from semen samp …
  • Jadason Enterprises Limited (J03):企業の財務・戦略的SWOT分析
    Jadason Enterprises Limited (J03) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and we …
  • Deutsche Ruckversicherung AG:企業の戦略・SWOT・財務情報
    Deutsche Ruckversicherung AG - Strategy, SWOT and Corporate Finance Report Summary Deutsche Ruckversicherung AG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • Taisei Lamick Co., Ltd.:企業の戦略・SWOT・財務情報
    Taisei Lamick Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Taisei Lamick Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Elos Medtech AB (ELOS B):企業の財務・戦略的SWOT分析
    Elos Medtech AB (ELOS B) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆